周五盘中，ANI制药（ANI Pharmaceuticals, Inc.）股价大幅上涨5.29%，引发市场关注。这一显著涨幅主要源于公司发布的强劲财报和乐观展望。
根据公司公布的最新财务报告，ANI制药第三季度业绩表现出色，超出市场预期。公司每股收益达到2.04美元，远高于分析师平均预期的1.75美元。同时，第三季度营收也超过了分析师的预测，达到2.1104亿美元以上。
更令投资者振奋的是，ANI制药上调了2025财年的收入指引。公司现预计全年营收将在8.54亿至8.73亿美元之间，较此前8.18亿至8.43亿美元的预期有显著提升。这一新指引也高于分析师们预计的844.68百万美元，展现了公司管理层对未来业务增长的信心。
值得注意的是，ANI制药的股价在今年表现强劲。截至上一交易日，公司股价已累计上涨63.2%。这次财报超预期和上调全年指引进一步增强了投资者对公司未来发展的信心，推动股价在当日交易中大幅上扬。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.